Study Of An Investigational Drug For Relapsing Multiple Sclerosis
Seeking adults aged 81-60 with relapsing multiple sclerosis for a study of an investigational drug given as a weekly injection.
Seeking adults aged 81-60 with relapsing multiple sclerosis for a study of an investigational drug given as a weekly injection.
Seeking adults healthy volunteers and people with skin conditions such as skin lupus (cutaneous lupus erythematosus, CLE), scarring hair loss (primary cicatricial alopecias, PCAs), blistering conditions (pemphigus and pemphigoid conditions), scarring/fibrosis (scleroderma/morphea), and cancer (cutaneous T and B cell lymphomas) for a study collecting skin samples.
Seeking adults with Moderate to Severe Systemic Lupus Erythematosus for a study of an investigational drug that has previously been approved for use in arthritis.
Seeking adults diagnosed with skin-limited lupus (cutaneous lupus erythematosus or CLE) for a study collecting blood and skin samples to better predict the risk of progression to systemic disease (systemic lupus erythematosus or SLE).
Seeking men and women whose Systemic lupus erythematosus (SLE) is causing damage to their kidneys (refractory lupus nephritis) for a study of an investigational cell therapy
Seeking men and women with Systemic Lupus Erythematous(SLE) and Lupus Nephritis for a biorepository study to collect health information and biological samples to help researchers learn more about the disease and help design future studies.
Seeking men and women whose rheumatoid arthritis has not responded to TNF-biologic treatment for a study comparing two different types of treatments (non-TNFi-biologic and tsDMARDs).
Seeking adults who have inflammatory arthritis and who are willing to provide data by answering questionnaires, giving a blood sample and donating leftover tissue samples for a study to help researchers better understand inflammatory arthritis.
Seeking men and women aged 18-60 years old with secondary progressive multiple sclerosis (MS) with no relapses (nrSPMS) for a study of an investigational drug
Seeking men and women aged 18 to 65 with relapsing multiple sclerosis who have either not started, or have discontinued treatment with a disease modifying therapy for a study of an investigational drug.
Seeking people who been diagnosed with Multiple Sclerosis (MS) or a similar immune disorder of the central nervous system or their immediate family members for a study to better understand what causes these diseases and perhaps improve treatment.
Newly diagnosed (within 6 months) people with Multiple Sclerosis (MS) sought for a trial comparing "first line" (traditional) with "second line" (aggressive) treatments in preventing disability. This is a pragmatic trial which means that even though participants will be randomly assigned a treatment group, they and their doctor can change their treatment if needed.
We are collecting data and biological samples from people with infectious or inflammatory conditions of the bowel such as celiac disease, colitis, and Inflammatory Bowel Disease (IBD) and from people who do not have bowel disease to get a better understanding of these diseases.
Seeking blood samples from healthy volunteers and volunteers who have various autoimmune diseases, like type 1 diabetes
Seeking men and women with Active Systemic Lupus Erythematosus (SLE) to undergo testing of CABA-201, an Autologous CD19-specific Chimeric Antigen Receptor T cells,
We are studying how skin diseases occur in the skin, including how immune cells choose to initiate disease as well as what causes them to enter the skin.
Seeking men and women with or without an inflammatory skin disease ( such as cutaneous lupus erythematosus, dermatomyositis, atopic dermatitis, alopecia areata, scleroderma, eczema, psoriasis, vitilago, or drug hypersensitivity) for a study to learn more about skin diseases and their response to light.